Aurora A Kinase Inhibitor MLN8237 in Treating Patients With Unresectable Stage III-IV Melanoma

Clinical trial NCT01316692 · TERMINATED

Trial details

NCT number: NCT01316692
Sponsor: Vanderbilt-Ingram Cancer Center
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent Melanoma Stage IIIc Melanoma Stage IV Melanoma

Start date: 2011-10-01
Primary completion: 2014-11-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.